- Home
- HQL vs KIO Comparison
HQL vs KIO Comparison
Compare HQL & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HQL | KIO |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.8M | 470.1M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | HQL | KIO |
|---|---|---|
| Price | $16.57 | $10.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 122.0K | ★ 369.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.55 | $10.69 |
| 52 Week High | $17.80 | $12.83 |
Technical Indicators
Market Signals| Indicator | HQL | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 29.09 |
| Support Level | $16.40 | N/A |
| Resistance Level | $17.51 | $12.51 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 60.14 | 23.00 |
Price Performance
Historical ComparisonAbout HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.